Science and Enterprise

Tag: equity

  • Finance Friday: 4 March 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter. Biomedical/Life Sciences Retina Implant AG in Reutlingen, Germany, a medical device company developing sub-retinal implants to help visually impaired people improve their sight, secured $18 million in its second round of equity funding from…

  • Venture Fund to Finance Univ. Tech. Start Ups

    Osage University Partners in Bala Cynwyd, Pennsylvania says it completed fund raising for its first venture capital fund financing new enterprises that license technology developed in university labs. The company says the fund, called Osage University Partners 1, achieved its goal of raising $100 million. Osage University Partners was founded in 2009 by venture professionals…

  • Finance Friday: 25 February 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy. Biomedical/Life Sciences CardioFocus in Marlborough, Massachusetts. Attrial fibrilliation devices. $13.6 million in equity financing. CalciMedica in San Diego, California. Biotech with experimental psoriasis candidate. $6 million in venture financing. Acetylon Pharmaceuticals, in Boston, Massacusetts. Drugs to treat cancer…

  • Finance Friday: 18 February 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and elsewhere. Biomedical/Life Sciences Rosetta Genomics Ltd. in Philadelphia, Pennsylvania. MicroRNA-based molecular diagnostics. $6.0 million, equity. Versartis in Mountain View, California. Protein drugs for endocrine disorders. $21 million in Series B equity financing. Ivivi Health Sciences in San…

  • Kauffman Grant Supports Seed Accelerator Network

    The Ewing Marion Kauffman Foundation in Kansas City, Missouri was awarded a $200,000 grant to TechStars, a network of regional start-up business accelerator programs, based in Boulder, Colorado. The TechStars network began on 31 January as part of a White House initiative encouraging entrepreneurship. The Kauffman funding will be used by the TechStars network to…

  • Sanofi-aventis Acquires Genzyme in $20.1B Deal

    Sanofi-aventis, the Paris-based pharmaceutical company, has acquired biotechnology company Genzyme Corporation in Cambridge, Massachusetts for $74.00 per share, or about $20.1 billion. The deal includes other payments to Genzyme shareholders based on net sales and developments involving specific Genzyme drugs. Genzyme is expected to add its treatments for several rare diseases to Sanofi-aventis’s current collection…

  • Finance Friday: 11 February 2011

    Here are recent financial transactions for science- and engineering-based companies reported by Xconomy. Biomedical/Life Sciences AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00. Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25. Fluidigm in South San Francisco, California. $75.6 million…

  • SBA Commits $2 Billion to Matching Small Business Capital

    The White House says the Small Business Administration (SBA) will commit $2 billion in matching funds to private sector investment over the next five years in promising high-growth companies.  The new funding is part of a White House small business initiative announced today that includes a proposal to make permanent a capital gains tax credit…

  • Finance Friday: 28 January 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies reported by Xconomy. Biomedical/Life Sciences Meritage Pharma in San Diego, California. Specialty drug discovery and development. $2 million, equity. XDx in Brisbane, California. Molecular diagnostics. $12.5 million, debt (from GE Capital) Stromedix in Cambridge, Massachusetts. Specialty drug discovery and development. $2 million,…

  • Finance Friday: 21 January 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies reported by CB Insights … Biomedical/Life sciences Fluidigm in South San Francisco, California. Medical devices and equipment. $5 million, debt Cognition Therapeutics in Pittsburgh, Pennsylvania. Discovery and development of small molecule therapeutics. $2.5 million, series A equity Adhezion Biomedica in Wyomissing, Pennsylvania.…